Aromatase inhibitors for breast cancer prevention

被引:100
作者
Cuzick, J [1 ]
机构
[1] Wolfson Inst Prevent Med, Ctr Epidemiol Math & Stat, Canc Res UK, London EC1M 6BQ, England
关键词
D O I
10.1200/JCO.2005.11.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1636 / 1643
页数:8
相关论文
共 36 条
[11]  
2-7
[12]  
CARRION RP, 1994, ANN ONCOL S7, V5, pS19
[13]   Influence of estrogen plus progestin on breast, cancer and mammography in healthy postmenopausal women - The Women's Health Initiative Randomized trial [J].
Chlebowski, RT ;
Hendrix, SL ;
Langer, RD ;
Stefanick, ML ;
Gass, M ;
Lane, D ;
Rodabough, RJ ;
Gilligan, MA ;
Cyr, MG ;
Thomson, CA ;
Khandekar, J ;
Petrovitch, H ;
McTiernan, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24) :3243-3253
[14]   A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer [J].
Coombes, RC ;
Hall, E ;
Gibson, LJ ;
Paridaens, R ;
Jassem, J ;
Delozier, T ;
Jones, SE ;
Alvarez, I ;
Bertelli, G ;
Ortmann, O ;
Coates, AS ;
Bajetta, E ;
Dodwell, D ;
Coleman, RE ;
Fallowfield, LJ ;
Mickiewicz, E ;
Andersen, J ;
Lonning, PE ;
Cocconi, G ;
Stewart, A ;
Stuart, N ;
Snowdon, CF ;
Carpentieri, M ;
Massimini, G ;
Bliss, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1081-1092
[15]   Overview of the main outcomes in breast-cancer prevention trials [J].
Cuzick, J ;
Powles, T ;
Veronesi, U ;
Forbes, J ;
Edwards, R ;
Ashley, S ;
Boyle, P .
LANCET, 2003, 361 (9354) :296-300
[16]   Letrozole, a new oral aromatase inhibitor for advanced breast cancer: Double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate [J].
Dombernowsky, P ;
Smith, I ;
Falkson, G ;
Leonard, R ;
Panasci, L ;
Bellmunt, J ;
Bezwoda, W ;
Gardin, G ;
Gudgeon, A ;
Morgan, M ;
Fornasiero, A ;
Hoffmann, W ;
Michel, J ;
Hatschek, T ;
Tjabbes, T ;
Chaudri, HA ;
Hornberger, U ;
Trunet, PF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :453-461
[17]  
Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606
[18]  
Falkson CI, 1996, ANN ONCOL, V7, P465
[19]  
GALE KE, 1994, CANCER, V73, P354, DOI 10.1002/1097-0142(19940115)73:2<354::AID-CNCR2820730220>3.0.CO
[20]  
2-J